LI KANG BIOMEDICAL Co. Ltd.(TW:6242)
NT$33.50+2.00 (+6.35%)
TW:6242
LI KANG BIOMEDICAL Co. Ltd. Revenue
NT$33.50
At close:+2.00 (+6.35%)
LI KANG BIOMEDICAL Co. Ltd. (6242) Revenue
LI KANG BIOMEDICAL Co. Ltd. Revenue
LI KANG BIOMEDICAL Co. Ltd. had a revenue of 161.99M in the quarter ending Jun 30, 2026, with 33.26%. This bring the company's revenue in the last twelve months to 573.36M, Decreased 0.45%. In the fiscal year ending Dec 31, 2025, LI KANG BIOMEDICAL Co. Ltd. had annual revenue of 589.21M with 4.19% growth.
- Revenue (ttm)
- 573.36M
- Revenue Growth
- -0.93%
- P/S Ratio
- 1.81
- Revenue/Employee
- TWD 4,532,377
- Employees
- 130
- Market Cap
- TWD 1.07B
Revenue Chart
LI KANG BIOMEDICAL Co. Ltd. Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 589.21M | 23.69M | 4.19% |
| Dec 31, 2024 | 565.51M | -63.86M | -10.15% |
| Dec 31, 2023 | 629.38M | -54.87M | -8.02% |
| Dec 31, 2022 | 684.25M | 297.28M | 76.82% |
| Dec 31, 2021 | 386.97M | -69.75M | -15.27% |
| Dec 31, 2020 | 456.72M | -26.58M | -5.50% |
| Dec 31, 2019 | 483.30M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.